Global private equity and venture capital news and research

Posts Tagged ‘Abingworth Management’

30 October 2014

PE-backed Sientra raises $75m IPO

stock Private equity-backed breast implant seller Sientra has raised $75m for its IPO.

26 February 2014

Abingworth closes sixth fund above target

life science test tube_sq UK life sciences-focused firm Abingworth Management is reportedly nearing a final close for its sixth fund, which has been oversubscribed.

22 January 2014

Venture capital-backed Dicerna prices IPO at $11 to $13 per share

Venture capital-backed RNA interference-based therapeutics developer Dicerna Pharmaceuticals has priced its IPO at $11 to $13 per share.

1 August 2013

RA Capital backs mammoth $60m Series C round for RNA Interference

RA Capital has helped emerging pharmaceutical company RNA Interference close an enormous $60m Series C financing round.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016